127 related articles for article (PubMed ID: 30019909)
1. Prognostic utility of neutrophil-to-lymphocyte and platelets-to-lymphocyte ratio in predicting biochemical recurrence post robotic prostatectomy.
Zanaty M; Ajib K; Alnazari M; El Rassy E; Aoun F; Zorn KC; El-Hakim A
Biomark Med; 2018 Aug; 12(8):841-848. PubMed ID: 30019909
[TBL] [Abstract][Full Text] [Related]
2. High preoperative neutrophil-lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy.
Lee H; Jeong SJ; Hong SK; Byun SS; Lee SE; Oh JJ
World J Urol; 2016 Jun; 34(6):821-7. PubMed ID: 26449784
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of biochemical recurrence-free survival after radical prostatectomy by cancer of the prostate risk assessment post-surgical (CAPRA-S) score.
Aktas BK; Ozden C; Bulut S; Tagci S; Erbay G; Gokkaya CS; Baykam MM; Memis A
Asian Pac J Cancer Prev; 2015; 16(6):2527-30. PubMed ID: 25824791
[TBL] [Abstract][Full Text] [Related]
4. The preoperative neutrophil-to-lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy.
Cao Z; Ji J; Zhang C; Wang F; Xu H; Yu Y; Sun Y
Cancer Med; 2019 Mar; 8(3):1004-1012. PubMed ID: 30693666
[TBL] [Abstract][Full Text] [Related]
5. The impact of single positive surgical margin features on biochemical recurrence after robotic radical prostatectomy.
Evren I; Hacıislamoğlu A; Ekşi M; Yavuzsan AH; Baytekin F; Çolakoğlu Y; Canoğlu D; Tugcu V
Int Braz J Urol; 2019; 45(1):45-53. PubMed ID: 30325603
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database.
Vidal AC; Howard LE; de Hoedt A; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Taioli E; Fowke JH; Freedland SJ
Cancer Causes Control; 2018 Jun; 29(6):581-588. PubMed ID: 29663110
[TBL] [Abstract][Full Text] [Related]
8. Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy.
Özsoy M; Moschini M; Fajkovic H; Soria F; Seitz C; Klatte T; Gust K; Briganti A; Karakiewicz PI; Roupret M; Kramer G; Shariat SF
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):100-105. PubMed ID: 29230007
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience.
Tanimoto R; Fashola Y; Scotland KB; Calvaresi AE; Gomella LG; Trabulsi EJ; Lallas CD
BMC Urol; 2015 Apr; 15():27. PubMed ID: 25879548
[TBL] [Abstract][Full Text] [Related]
10. Positive surgical margins and biochemical recurrence following minimally-invasive radical prostatectomy - An analysis of outcomes from a UK tertiary referral centre.
Sachdeva A; Veeratterapillay R; Voysey A; Kelly K; Johnson MI; Aning J; Soomro NA
BMC Urol; 2017 Oct; 17(1):91. PubMed ID: 28969608
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of neutrophil-to-lymphocyte ratio as a prognostic indicator in a Singapore cohort of patients with clinically localized prostate cancer treated with prostatectomy.
Lu Y; Huang HH; Lau WKO
World J Urol; 2020 Jan; 38(1):103-109. PubMed ID: 30953141
[TBL] [Abstract][Full Text] [Related]
12. The factors predicting biochemical recurrence in patients with radical prostatectomy.
Koca O; Ün S; Türk H; Zorlu F
Arch Ital Urol Androl; 2016 Jan; 87(4):270-5. PubMed ID: 26766796
[TBL] [Abstract][Full Text] [Related]
13. Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy.
Schroeck FR; Sun L; Freedland SJ; Jayachandran J; Robertson CN; Moul JW
Prostate Cancer Prostatic Dis; 2008; 11(4):371-6. PubMed ID: 18427570
[TBL] [Abstract][Full Text] [Related]
14. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
[TBL] [Abstract][Full Text] [Related]
15. Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.
Gandaglia G; De Lorenzis E; Novara G; Fossati N; De Groote R; Dovey Z; Suardi N; Montorsi F; Briganti A; Rocco B; Mottrie A
Eur Urol; 2017 Feb; 71(2):249-256. PubMed ID: 27209538
[TBL] [Abstract][Full Text] [Related]
16. Predictors of positive surgical margins after radical prostatectomy at a single institution: preoperative and pathologic factors, and the impact of surgeon variability and technique on incidence and location.
Lallas CD; Fashola Y; Den RB; Gelpi-Hammerschmidt F; Calvaresi AE; McCue P; Birbe R; Gomella LG; Trabulsi EJ
Can J Urol; 2014 Oct; 21(5):7479-86. PubMed ID: 25347375
[TBL] [Abstract][Full Text] [Related]
17. Importance of neutrophil/lymphocyte ratio in prediction of PSA recurrence after radical prostatectomy.
Gazel E; Tastemur S; Acikgoz O; Yigman M; Olcucuoglu E; Camtosun A; Ceylan C; Ates C
Asian Pac J Cancer Prev; 2015; 16(5):1813-6. PubMed ID: 25773829
[TBL] [Abstract][Full Text] [Related]
18. Can we use neutrophil to lymphocyte ratio in the diagnosis and prediction of extracapsular extension in localized prostate cancer?
Merder E; Arıman A; Dinçer S; Altunrende F
Urologia; 2022 May; 89(2):203-209. PubMed ID: 33960239
[TBL] [Abstract][Full Text] [Related]
19. Biochemical recurrence rates are similar for pT2-positive surgical margins and pT3a.
Leite KR; Hartmann C; Reis ST; Viana N; Dall'Oglio MF; Sant'Anna AC; Nesrallah A; Nesrallah L; Antunes AA; Camara-Lopes LH; Srougi M
Int Braz J Urol; 2014; 40(2):146-53. PubMed ID: 24856481
[TBL] [Abstract][Full Text] [Related]
20. Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database.
Freedland SJ; Aronson W; Presti JC; Kane CJ; Terris MK; Elashoff D; Amling CL;
J Urol; 2003 Jun; 169(6):2142-6. PubMed ID: 12771736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]